You have 9 free searches left this month | to do more
Showing 1 - 25 of
2,288 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Not yet recruiting
  • Relapsed Sarcomas
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
2022-01-14
Jan 14, 2022
M
Completed
  • Breast Cancer
  • Trastuzumab and non-pegylated liposomal doxorubicin
  • Paris, France
  • +3 more
2022-02-08
Feb 8, 2022
S
Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
2021-11-15
Nov 15, 2021
Y
Terminated
  • Relapsed Lymphomas
  • Refractory Lymphomas
  • Vorinostat
  • Pegylated Liposomal Doxorubicin (PLD), Doxil
  • New Haven, Connecticut
    Yale University School of Medicine
2022-03-29
Mar 29, 2022
S
Recruiting
  • Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
  • Blood sampling
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
2021-12-21
Dec 21, 2021
N
Recruiting
  • Kaposi Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
H
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
  • +1 more
2022-01-11
Jan 11, 2022
A
Active, not recruiting
  • Solid Tumors
  • Milano, Italy
  • +2 more
2021-11-17
Nov 17, 2021
M
Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-18
Feb 18, 2022
R
Recruiting
  • Lymphoma
  • liposomal doxorubicin
  • Shanghai, Shanghai, China
    Ruijin Hospital
2021-03-13
Mar 13, 2021
G
Active, not recruiting
  • Ovarian Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
2021-07-21
Jul 21, 2021
Y
Recruiting
  • Stage III Adult Soft Tissue Sarcoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2021-02-18
Feb 18, 2021
A
Recruiting
  • Pediatric Cancer
  • +9 more
  • Magnetic resonance high intensity focused ultrasound
  • Lyso-thermosensitive liposomal doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
2021-12-10
Dec 10, 2021
N
Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Bethesda, Maryland
    National Cancer Institute Developmental Therapeutics Clinic
2022-03-17
Mar 17, 2022
T
Recruiting
  • Ovarian Cancer
  • +5 more
  • TTI-622
  • Pegylated Liposomal Doxorubicin
  • Houston, Texas
    Oncology Consultants, P.A.
2022-03-14
Mar 14, 2022
R
Suspended
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • pegylated liposomal doxorubicin hydrochloride
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
2021-09-20
Sep 20, 2021
N
Suspended
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +25 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
2022-04-05
Apr 5, 2022
N
Completed
  • Ovarian Neoplasms Malignant (Excl Germ Cell)
  • +2 more
  • trientine dihydrochloride
  • +2 more
  • (no location specified)
2020-10-18
Oct 18, 2020
D
Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
2021-09-03
Sep 3, 2021
W
Not yet recruiting
  • Breast Cancer
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College of HUST
2021-10-27
Oct 27, 2021
H
Terminated
  • Ovarian Cancer
  • Doxil (Pegylated Liposomal Doxorubicin)
  • BIBF 1120
  • Indianapolis, Indiana
  • +1 more
2022-02-14
Feb 14, 2022
M
Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Phoenix, Arizona
  • +2 more
2021-04-06
Apr 6, 2021